Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in <i>EGFR</i>-Mutated NSCLC

The liquid biopsy has the potential to improve patient care in the diagnostic and therapeutic setting in non-small cell lung cancer (NSCLC). Consented patients with epidermal growth factor receptor (<i>EGFR</i>) positive disease (<i>n</i> = 21) were stratified into two cohort...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Martin P. Barr, Anne-Marie Baird, Sophia Halliday, Petra Martin, Emma H. Allott, James Phelan, Greg Korpanty, Linda Coate, Cathal O’Brien, Steven G. Gray, Jane S. Y. Sui, Brian Hayes, Sinead Cuffe, Stephen P. Finn
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Subjects:	EGFR liquid biopsy T790M biomarkers CTCs NGS
Online Access:	https://www.mdpi.com/2075-4418/12/10/2360